PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 18, 2008Cardiology27 citations

Patient Characteristics in Cases of Chronic Severe Heart Failure with Different Degrees of Left Ventricular Systolic Dysfunction

View Full Paper
SESven V. ErikssonJKJohn KjekshusJOJ T Offstad

Key Result

Fractional shortening >14% in severe heart failure was associated with older age (74 vs 68 years, p<0.01), female sex (48% vs 15%, p<0.05), and better survival in the placebo group.

Key Points

  • To determine whether baseline patient characteristics and long-term survival differ based on the severity of left ventricular systolic dysfunction in severe congestive heart failure.
  • Assessed an optional protocol subgroup of 54 patients with NYHA class IV congestive heart failure from the CONSENSUS-I trial using M-mode echocardiography.
  • Stratified patients by median left ventricular fractional shortening (14%) to compare demographics and assessed 2-year follow-up survival between enalapril and placebo arms.
  • Patients with fractional shortening above 14% were significantly older (74 ± 7 vs. 68 ± 7 years, p < 0.01), more frequently female (48% vs. 15%, p < 0.05), and presented with lower heart rates (77 ± 15 vs. 95 ± 17 beats/min, p < 0.01).
  • In the placebo group, patients with fractional shortening > 14% had significantly better 2-year prognosis than those with fractional shortening < 14%, whereas enalapril treatment eliminated this survival difference.

Study Design

Type

RCT (n=54)

Structured PICO

Do patients with severe chronic congestive heart failure differ in demographic characteristics and prognosis based on the degree of left ventricular systolic dysfunction?

P
Population
54 patients with severe chronic congestive heart failure (NYHA IV) from the CONSENSUS-I trial evaluated with M-mode echocardiography
I
Intervention
Enalapril
C
Comparator
Placebo
O
Outcome
Demographic characteristics and 2-year survival based on degree of left ventricular fractional shortening (FS > 14% vs < 14%)hard clinical

In severe heart failure, patients with less severe systolic dysfunction (FS > 14%) are older, more often female, and have a better natural prognosis that is modified by enalapril therapy.

Abstract

It has not been determined previously whether patients with severe chronic congestive heart failure differ in demographic characteristics with respect to left ventricular systolic dysfunction (LVD). In patients with severe chronic congestive heart failure in NYHA IV, an optional protocol in the CONSENSUS-I trial was designed to ascertain whether there were any differences in patient characteristics regarding the degree of LVD defined as left ventricular fractional shortening (FS). A subgroup of 54 patients from the CONSENSUS-I trial were evaluated with M-mode echocardiography. Patients with FS above median (14%) were older (74 +/- 7 vs. 68 +/- 7, p 14% had significantly better prognosis than patients with FS < 14%. In the enalapril-treated group no such difference in survival was seen. The difference between the original treatment groups remained, despite the fact that treatment with enalapril was then made available to all surviving patients. In conclusion, patients with advanced chronic congestive heart failure and less severe LVD have different demographic characteristics than patients with more severe LVD. In the placebo group, but not in the enalapril group, prognosis was better in patients with less severe LVD.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Eriksson et al. (2008) conducted an RCT in Severe chronic congestive heart failure (NYHA IV) (n=54). Enalapril vs. Placebo was evaluated on Differences in patient characteristics and survival based on degree of left ventricular systolic dysfunction (fractional shortening >14% vs <14%). Fractional shortening >14% in severe heart failure was associated with older age (74 vs 68 years, p<0.01), female sex (48% vs 15%, p<0.05), and better survival in the placebo group.

synapsesocial.com/papers/6a0ea5ec25c30b2cc7f9a3e2https://doi.org/10.1159/000176668
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heart failure in patients with preserved and deteriorated left ventricular ejection fraction2005 · 83 citations
  2. 2Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction2002 · 83 citations
  3. 3An abnormal ECG with inverted T waves in the precordial leads: confirming the diagnosis with contrast enhanced echocardiography2005 · 4 citations
  4. 4Sex Differences in Patients With Chronic Heart Failure With Reference to Left Ventricular Ejection Fraction2018 · 4 citations
  5. 5Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fraction2026